Skip to main content
Caplight Logo









OutSense Diagnostics

OutSense Diagnostics

Private
Or YehudaHealthcare & Life Scienceshttps://www.kohlerhealth.com/

Last Round

Series A

Jun 7, 2021

Total Funding Raised

$2.76M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

OutSense Diagnostics is a health technology company that develops AI-powered IoT medical devices for non-invasive, continuous monitoring and early detection of health conditions through the analysis of human waste.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Consumer Electronics, Sensors

Business Model

B2B2C

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Application

Keywords

smart toilet sensorhealth monitoringremote patient monitoringRPMdigital healthoptical spectroscopycomputer visionIoT health devicesmart bathroomgut health trackingpreventative healthhealth techwearablesmedtechfemtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OutSense Diagnostics Comparables

Compare OutSense Diagnostics with similar companies based on industry and business-model similarity.

OutSense Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Olive Diagnostics
81%
Throne Science
81%
Withings
78%

OutSense Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 7, 2021
GrantApr 1, 2019
AcceleratorJan 31, 2016

Key People

Founding team and executive leadership

Kash Kapadia

President, Chief Executive Officer, Board Chair

Executive Team

OutSense Diagnostics Investors

Notable investors and investment history

OutSense Diagnostics investors
InvestorRounds
Israel Innovation AuthorityAccelerator
Longevity Venture PartnersSeries A
Peregrine VenturesAccelerator, Series A
Incentive IncubatorAccelerator
European UnionGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2026

    Monthly visitors increased 33% MoM.

  • Aug 20, 2026

    Monthly visitors increased 85% MoM.

OutSense Diagnostics Filings

Explore SEC and related filing metadata, where available.

OutSense Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OutSense Diagnostics's valuation, stock price, and market status.

Is OutSense Diagnostics a public or private company?

OutSense Diagnostics is a private company.

What is the current stock price of OutSense Diagnostics?

OutSense Diagnostics is a private company, so its shares have no public market price. Caplight tracks OutSense Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is OutSense Diagnostics worth (valuation)?

Valuation information for OutSense Diagnostics is not publicly available.

Can I buy OutSense Diagnostics stock?

OutSense Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was OutSense Diagnostics's last funding round?

OutSense Diagnostics's most recent funding round was Series A on June 7, 2021.

Who are the main investors in OutSense Diagnostics?

Key investors in OutSense Diagnostics include Peregrine Ventures.

Will OutSense Diagnostics IPO soon?

No public IPO plans have been announced for OutSense Diagnostics.

How can I track OutSense Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades in OutSense Diagnostics's shares on secondary markets.

Firmographic Details

HeadquartersOr Yehuda
Employee Range40
Year Founded2016
Last FundingJun 7, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?